CiRC Biosciences: Funding, Investors & Team (Oct 2026)
CiRC Biosciences is a biotechnology company that specializes in developing potential cell therapy treatments for conditions such as retinitis pigmentosa and dry age-related macular degeneration, which both involve vision loss. Currently in the pre-clinical development stage, the company is finding innovative solutions for these conditions. CiRC Biosciences is a subsidiary of Paragon Biosciences.
CiRC Biosciences has raised $7.0M across 1 funding round on record, the most recent an undisclosed round of $7.0M announced in May 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CiRC Biosciences Company Profile and Key Stats
Latest funding round on record: May 2024.
CiRC Biosciences Funding Rounds
CiRC Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
CiRC Biosciences Funding Compared to Other Biotechnology Startups
CiRC Biosciences' latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CiRC Biosciences in Biotechnology and Chicago
Companies Similar to CiRC Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
CiRC Biosciences Funding FAQs
What does CiRC Biosciences do?
CiRC Biosciences is a biotechnology company that specializes in developing potential cell therapy treatments for conditions such as retinitis pigmentosa and dry age-related macular degeneration, which both involve vision loss. Currently in the pre-clinical development stage, the company is finding innovative solutions for these conditions. CiRC Biosciences is a subsidiary of Paragon Biosciences.
How much funding has CiRC Biosciences raised?
CiRC Biosciences has raised $7.0M across 1 round on record. The most recent is an undisclosed round of $7.0M announced in May 2024.
When did CiRC Biosciences last raise funding?
CiRC Biosciences' most recent funding round on record is an undisclosed round of $7.0M, announced in May 2024.
Who founded CiRC Biosciences?
FundedIQ lists Sai Chavala (Founder) at CiRC Biosciences.
Where is CiRC Biosciences headquartered?
CiRC Biosciences is based in Chicago, Illinois, United States.
How many employees does CiRC Biosciences have?
CiRC Biosciences is in the 11-50 employee band.
How does CiRC Biosciences' funding compare to other Biotechnology startups?
CiRC Biosciences' latest round of $7.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CiRC Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CiRC Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.